Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mexiletine for the Treatment of Muscle Cramps in ALS

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by University of California, Davis
Sponsor:
Collaborators:
University of California, Davis
ALS Association
Information provided by (Responsible Party):
Bjorn Oskarsson, MD, University of California, Davis
ClinicalTrials.gov Identifier:
NCT01811355
First received: March 6, 2013
Last updated: October 14, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)